Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice.
Autosomal dominant GH deficiency type II (IGHDII) is often associated with mutations in the human GH gene (GH1) that give rise to products lacking exon-3 ((Deltaexon3)hGH). In the heterozygous state, these act as dominant negative mutations that prevent the release of human pituitary GH (hGH). To de...
Auteurs principaux: | McGuinness, L, Magoulas, C, Sesay, A, Mathers, K, Carmignac, D, Manneville, J, Christian, H, Phillips, J, Robinson, I |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2003
|
Documents similaires
-
A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice.
par: Magoulas, C, et autres
Publié: (2000) -
Increasing hub disruption parallels dementia severity in autosomal
dominant Alzheimer’s disease
Publié: (2024-10-01) -
Autosomal Dominant Alternating Hemiplegia
par: J Gordon Millichap
Publié: (1993-01-01) -
Autosomal Dominant Partial Epilepsies
par: J Gordon Millichap
Publié: (2000-07-01) -
Autosomal Dominant Juvenile Amyotrophic LS
par: J Gordon Millichap
Publié: (1999-09-01)